From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.
|
Compound class:
Synthetic organic
Comment: Compound 4 is from a series of antimalarial hexahydropyrimidine analogues claimed in UCB Biopharma patent WO2022008639A1 [1].
|
|
|||||||||||||||||||||||||||||||||||
| compound 4 [WO2022008639A1] has been tagged as relevant to malaria pharmacology and is awaiting detailed curation for the Guide to MALARIA PHARMACOLOGY. |